Actio Biosciences to Be Acquired by Jazz Pharmaceuticals for Up to $1.32 Billion
August 11, 2026
August 11, 2026
PALO ALTO, California, Aug. 11 -- Cooley, a law firm, issued the following news release:
* * *
Actio Biosciences to Be Acquired by Jazz Pharmaceuticals for Up to $1.32 Billion
Cooley advised Actio Biosciences, a clinical-stage biotechnology company advancing the translation of genetic insights into novel small molecule precision medicines, on its agreement to be acquired by Jazz Pharmaceuticals for $820 million upfront payment and up to $500 million in pote . . .
* * *
Actio Biosciences to Be Acquired by Jazz Pharmaceuticals for Up to $1.32 Billion
Cooley advised Actio Biosciences, a clinical-stage biotechnology company advancing the translation of genetic insights into novel small molecule precision medicines, on its agreement to be acquired by Jazz Pharmaceuticals for $820 million upfront payment and up to $500 million in pote . . .